craft-sa-dev Home  

PMC:1892049 / 15840-16406 JSONTXT 4 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T16245 0-7 NNP denotes Western
T16246 8-12 NN denotes Blot
T16247 13-21 NN denotes Analysis
T16248 22-24 IN denotes of
T16249 25-30 NN denotes ITPR1
T16251 31-38 NN denotes Protein
T16250 39-45 NNS denotes Levels
T16252 46-48 IN denotes in
T16253 49-52 NN denotes EBV
T16255 53-65 VBN denotes Immortalized
T16254 66-78 NNS denotes Lymphoblasts
T16256 79-83 IN denotes from
T16257 84-88 NN denotes AUS1
T16259 89-95 NN denotes Family
T16258 96-103 NNS denotes Members
T16260 103-334 sentence denotes Western blot performed to examine ITPR1 levels in EBV immortalized lymphocytes from AUS1 affected family members carrying the ITPR1 deletion and from an AUS1 family member of unknown disease status who does not carry the deletion.
T16261 104-111 NNP denotes Western
T16262 112-116 NN denotes blot
T16263 117-126 VBN denotes performed
T16264 127-129 TO denotes to
T16265 130-137 VB denotes examine
T16266 138-143 NN denotes ITPR1
T16267 144-150 NNS denotes levels
T16268 151-153 IN denotes in
T16269 154-157 NN denotes EBV
T16271 158-170 VBN denotes immortalized
T16270 171-182 NNS denotes lymphocytes
T16272 183-187 IN denotes from
T16273 188-192 NN denotes AUS1
T16274 193-201 VBN denotes affected
T16276 202-208 NN denotes family
T16275 209-216 NNS denotes members
T16277 217-225 VBG denotes carrying
T16278 226-229 DT denotes the
T16280 230-235 NN denotes ITPR1
T16279 236-244 NN denotes deletion
T16281 245-248 CC denotes and
T16282 249-253 IN denotes from
T16283 254-256 DT denotes an
T16285 257-261 NN denotes AUS1
T16286 262-268 NN denotes family
T16284 269-275 NN denotes member
T16287 276-278 IN denotes of
T16288 279-286 JJ denotes unknown
T16290 287-294 NN denotes disease
T16289 295-301 NN denotes status
T16291 302-305 WP denotes who
T16293 306-310 VBZ denotes does
T16294 311-314 RB denotes not
T16292 315-320 VB denotes carry
T16295 321-324 DT denotes the
T16296 325-333 NN denotes deletion
T16297 333-334 . denotes .
T16298 334-430 sentence denotes Notably the samples from patients with ITPR1 deletion show a dramatic decrease in ITPR1 levels.
T16299 335-342 RB denotes Notably
T16301 343-346 DT denotes the
T16302 347-354 NNS denotes samples
T16303 355-359 IN denotes from
T16304 360-368 NNS denotes patients
T16305 369-373 IN denotes with
T16306 374-379 NN denotes ITPR1
T16307 380-388 NN denotes deletion
T16300 389-393 VBP denotes show
T16308 394-395 DT denotes a
T16310 396-404 JJ denotes dramatic
T16309 405-413 NN denotes decrease
T16311 414-416 IN denotes in
T16312 417-422 NN denotes ITPR1
T16313 423-429 NNS denotes levels
T16314 429-430 . denotes .
T16315 430-566 sentence denotes To demonstrate equal loading, these samples were diluted one in five, and the Western blot was repeated using an antibody against ACTB.
T16316 431-433 TO denotes To
T16317 434-445 VB denotes demonstrate
T16319 446-451 JJ denotes equal
T16320 452-459 NN denotes loading
T16321 459-461 , denotes ,
T16322 461-466 DT denotes these
T16323 467-474 NNS denotes samples
T16324 475-479 VBD denotes were
T16318 480-487 VBN denotes diluted
T16325 488-491 CD denotes one
T16326 492-494 IN denotes in
T16327 495-499 CD denotes five
T16328 499-501 , denotes ,
T16329 501-504 CC denotes and
T16330 505-508 DT denotes the
T16332 509-516 NNP denotes Western
T16331 517-521 NN denotes blot
T16334 522-525 VBD denotes was
T16333 526-534 VBN denotes repeated
T16335 535-540 VBG denotes using
T16336 541-543 DT denotes an
T16337 544-552 NN denotes antibody
T16338 553-560 IN denotes against
T16339 561-565 NN denotes ACTB
T16340 565-566 . denotes .
R4848 T16245 T16246 compound Western,Blot
R4849 T16246 T16247 compound Blot,Analysis
R4850 T16248 T16247 prep of,Analysis
R4851 T16249 T16250 compound ITPR1,Levels
R4852 T16250 T16248 pobj Levels,of
R4853 T16251 T16250 compound Protein,Levels
R4854 T16252 T16247 prep in,Analysis
R4855 T16253 T16254 nmod EBV,Lymphoblasts
R4856 T16254 T16252 pobj Lymphoblasts,in
R4857 T16255 T16254 amod Immortalized,Lymphoblasts
R4858 T16256 T16254 prep from,Lymphoblasts
R4859 T16257 T16258 compound AUS1,Members
R4860 T16258 T16256 pobj Members,from
R4861 T16259 T16258 compound Family,Members
R4862 T16261 T16262 compound Western,blot
R4863 T16263 T16262 acl performed,blot
R4864 T16264 T16265 aux to,examine
R4865 T16265 T16263 advcl examine,performed
R4866 T16266 T16267 compound ITPR1,levels
R4867 T16267 T16265 dobj levels,examine
R4868 T16268 T16267 prep in,levels
R4869 T16269 T16270 nmod EBV,lymphocytes
R4870 T16270 T16268 pobj lymphocytes,in
R4871 T16271 T16270 amod immortalized,lymphocytes
R4872 T16272 T16270 prep from,lymphocytes
R4873 T16273 T16274 npadvmod AUS1,affected
R4874 T16274 T16275 amod affected,members
R4875 T16275 T16272 pobj members,from
R4876 T16276 T16275 compound family,members
R4877 T16277 T16275 acl carrying,members
R4878 T16278 T16279 det the,deletion
R4879 T16279 T16277 dobj deletion,carrying
R4880 T16280 T16279 compound ITPR1,deletion
R4881 T16281 T16272 cc and,from
R4882 T16282 T16272 conj from,from
R4883 T16283 T16284 det an,member
R4884 T16284 T16282 pobj member,from
R4885 T16285 T16284 compound AUS1,member
R4886 T16286 T16284 compound family,member
R4887 T16287 T16284 prep of,member
R4888 T16288 T16289 amod unknown,status
R4889 T16289 T16287 pobj status,of
R4890 T16290 T16289 compound disease,status
R4891 T16291 T16292 dep who,carry
R4892 T16292 T16284 relcl carry,member
R4893 T16293 T16292 aux does,carry
R4894 T16294 T16292 neg not,carry
R4895 T16295 T16296 det the,deletion
R4896 T16296 T16292 dobj deletion,carry
R4897 T16297 T16262 punct .,blot
R4898 T16299 T16300 advmod Notably,show
R4899 T16301 T16302 det the,samples
R4900 T16302 T16300 nsubj samples,show
R4901 T16303 T16302 prep from,samples
R4902 T16304 T16303 pobj patients,from
R4903 T16305 T16304 prep with,patients
R4904 T16306 T16307 compound ITPR1,deletion
R4905 T16307 T16305 pobj deletion,with
R4906 T16308 T16309 det a,decrease
R4907 T16309 T16300 dobj decrease,show
R4908 T16310 T16309 amod dramatic,decrease
R4909 T16311 T16309 prep in,decrease
R4910 T16312 T16313 compound ITPR1,levels
R4911 T16313 T16311 pobj levels,in
R4912 T16314 T16300 punct .,show
R4913 T16316 T16317 aux To,demonstrate
R4914 T16317 T16318 advcl demonstrate,diluted
R4915 T16319 T16320 amod equal,loading
R4916 T16320 T16317 dobj loading,demonstrate
R4917 T16321 T16318 punct ", ",diluted
R4918 T16322 T16323 det these,samples
R4919 T16323 T16318 nsubjpass samples,diluted
R4920 T16324 T16318 auxpass were,diluted
R4921 T16325 T16318 npadvmod one,diluted
R4922 T16326 T16325 prep in,one
R4923 T16327 T16326 pobj five,in
R4924 T16328 T16318 punct ", ",diluted
R4925 T16329 T16318 cc and,diluted
R4926 T16330 T16331 det the,blot
R4927 T16331 T16333 nsubjpass blot,repeated
R4928 T16332 T16331 compound Western,blot
R4929 T16333 T16318 conj repeated,diluted
R4930 T16334 T16333 auxpass was,repeated
R4931 T16335 T16333 advcl using,repeated
R4932 T16336 T16337 det an,antibody
R4933 T16337 T16335 dobj antibody,using
R4934 T16338 T16337 prep against,antibody
R4935 T16339 T16338 pobj ACTB,against
R4936 T16340 T16318 punct .,diluted